Inhibitor Therapeutics (INTI) Cash from Financing Activities (2009 - 2023)
Inhibitor Therapeutics (INTI) recorded Cash from Financing Activities of -$411,000 in FY2023, compared with $180,000 in FY2022.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Cash from Financing Activities (2009 - 2023) Analysis & Trends
Starting with FY2013, Inhibitor Therapeutics' Cash from Financing Activities history includes 11 years.
- The FY2023 figure is the lowest annual Cash from Financing Activities since FY2017.
- Per Business Quant data, INTI's Cash from Financing Activities was $180,000 in FY2022 (+2.3%), $176,000 in FY2021 (+82.2%), $96,600 in FY2020 (-96.0%) and $2.4 million in FY2019 (-46.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Inhibitor Therapeutics | 13.90 Mn | 6.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -411,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Jun 30, 2021 | 75,000.00 |
| Mar 31, 2021 | 101,000.00 |
| Dec 31, 2020 | 55,000.00 |
| Jun 30, 2020 | 41,600.00 |
| Sep 30, 2019 | -99,178.00 |
| Jun 30, 2019 | 1.50 Mn |
| Mar 31, 2019 | 1.00 Mn |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 1.60 Mn |
| Jun 30, 2018 | 12,000.00 |
| Mar 31, 2018 | 2.36 Mn |
| Jun 30, 2017 | 49,500.00 |
| Mar 31, 2017 | -3.68 Mn |
| Dec 31, 2016 | 4.54 Mn |
| Dec 31, 2014 | 508,080.00 |
| Sep 30, 2014 | 486,750.00 |
API Access
Inhibitor Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();